Biography:
Abhay Tharmatt is currently a PhD scholar at BITS Pilani, India, specializing in the development of nanocarriers for therapeutic applications. He completed his B. Pharmacy from Lovely Professional University, Phagwara, and his M. Pharmacy in Pharmaceutics from Guru Nanak Dev University, Amritsar. Abhay's research focuses on the topical delivery of anti-VEGF nanomedicines for psoriasis using CRISPR/Cas9 gene editing. He has published several papers and is set to join the University of New South Wales for a research scholar program. His work aims to enhance treatment efficacy and safety in dermatological therapeutics.
Title : Targeted downregulation of VEGF-A to inhibit angiogenesis in psoriasis using CRISPR/Cas9 complexed lipopolymeric nanoplexes